Value of 11C-methionine PET in imaging brain tumours and metastases.
about
Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patientsDiffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumorsImaging metabolic heterogeneity in cancerBrain Vascular Imaging TechniquesSPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.Imaging biomarkers in primary brain tumours.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.PET Imaging of 18F-FDG, 11C-methionine, 11C-flumazenil, and 11C-4DST in Progressive Multifocal LeukoencephalopathyOptimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative AssessmentRegulation of Hematopoiesis and Methionine Homeostasis by mTORC1 Inhibitor NPRL2Imaging Spectrum and Pitfalls of (11)C-Methionine Positron Emission Tomography in a Series of Patients with Intracranial LesionsRelationship between the uptake of 18F-borono-L-phenylalanine and L-[methyl-11C] methionine in head and neck tumors and normal organs.Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.FDG-PET Contributions to the Pathophysiology of Memory Impairment.Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [(18) F]FDG-PET imaging. Is it of value in asymptomatic patients?Fluorine-18 patents (2009-2015). Part 1: novel radiotracers.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.FDG and Beyond.Optimization of scan initiation timing after 11C-methionine administration for the diagnosis of suspected recurrent brain tumors.Is DNA methylation the new guardian of the genome?11C-methionine PET/CT findings in benign brain disease.Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction.Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.Correlation of (18)F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool.Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft modelState-of-the-art considerations in small cell lung cancer brain metastases.Usefulness of (11)C-methionine positron emission tomography for detecting intracranial ameloblastic carcinoma: A case report.Diagnostic and Prognostic Significance of Methionine Uptake and Methionine Positron Emission Tomography Imaging in Gliomas.The wayward methyl group and the cascade to cancer.Prospective study of 11C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment.One-step synthesis of an 18F-labeled boron-derived methionine analog: a substitute for 11C-methionine?Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma.Accumulation of 11C-methionine in the normal pituitary gland on 11C-methionine PET.
P2860
Q26853308-629FB12B-0A28-4F05-82E8-795E4B8FADBCQ28067114-EFAE3B52-852B-4559-B9B0-FBA8CAB58977Q28076500-C2C400E6-A7BA-41B3-BE5A-E65F71E14CA5Q30363574-396E703F-7930-49E7-BB3F-E1F29FBDA684Q30828977-7739AC92-2593-4ED8-A413-7835BD5E43E3Q30880129-55A8D626-ECB8-4081-A133-3E6E901960D0Q31115540-661B568D-5C84-4FC4-95FA-46C022B871BCQ32182145-2AA23584-B378-4944-B0E2-7CBB13E0CF80Q33719890-684661DF-2FF2-4A7D-A00C-E49274C8FD4FQ33746805-5132D645-E0C2-4E1E-8914-31EC0535DF9CQ34348544-C093CAFB-882B-40EB-9031-B0630544F7EDQ35679377-7E2C78E4-053B-47D0-8A06-3070FD6443C9Q35689330-656D3480-52BC-450A-B03C-012B9BFDBA26Q36794326-749ACEB3-77F7-4A27-B816-7F94B0AA073AQ36829937-412FCFBE-C41E-454B-9671-5F1AB346A476Q37587107-C5665EC4-11BB-46BA-AAD6-4A261B7E7920Q37644820-B31E0F66-FD72-4745-967A-DF48D7461174Q38576278-7D04C549-6AB7-4CC0-845D-938F310B5BE6Q38644016-D3BAA804-CED0-4F15-8B56-A0CF71550169Q38670162-0C767DC9-A98F-4668-9FC1-575C405DF437Q38815396-CF16E7C1-DFDA-4B0B-A742-8BC57C18E321Q38869438-23EC1B4D-6823-4189-A154-3B6A44B97A81Q39155152-23FDE9A7-1DC7-4332-A811-F926F415E4E8Q39233074-E5FB4FAE-C1EA-4DEA-B4C0-8F484FCDC74EQ39249830-F03A5900-57BF-41DB-9CF0-F5497664152CQ41212276-1FF3E441-C19D-4675-BC2E-199BDDF56DCBQ41994160-F5F2144D-A853-46B5-B2B9-4CA5B2015EE2Q42022095-58DBE50E-4DFC-4C7B-A586-827F30A7D0BBQ42364589-2B448E91-3D79-4EAE-A21F-6FE0DFCD99C6Q42378525-21B43915-7FB5-4676-A70A-8D4426BD67ECQ42865361-EA61556D-BCF0-49BF-9315-B42823011981Q45898734-6A821AF0-20FD-4C2D-92F0-CA78BAAF187DQ46570903-F291302D-150B-4E2F-81E6-209530060949Q47109146-EFFA4EE3-C84A-4C58-9725-3FE69F6F33BEQ47724425-4FBE60FD-8D52-42DB-A7AB-4A7170949EF1Q47833074-13B8EB24-0ADC-43F3-86FB-944F09EB2BF4Q48158155-9342A30C-8E05-4372-B436-9215B7FA1756Q48241629-1D803761-78C7-4EF3-82CD-6DFD9E8B69A8Q48686036-F351A593-D33C-403A-94D0-008A35C7A717Q48690435-1FD424BD-1E71-4657-9723-35B2C3A945E7
P2860
Value of 11C-methionine PET in imaging brain tumours and metastases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Value of 11C-methionine PET in imaging brain tumours and metastases.
@en
type
label
Value of 11C-methionine PET in imaging brain tumours and metastases.
@en
prefLabel
Value of 11C-methionine PET in imaging brain tumours and metastases.
@en
P2093
P1476
Value of 11C-methionine PET in imaging brain tumours and metastases.
@en
P2093
Andor W J M Glaudemans
Annemiek M E Walenkamp
Mart A A M Heesters
Riemer H J A Slart
Roelien H Enting
Ronald W J van Rheenen
Rudi A J O Dierckx
P2888
P304
P356
10.1007/S00259-012-2295-5
P577
2012-12-12T00:00:00Z